Fate Therapeutics
FATE
#7766
Rank
C$0.32 B
Marketcap
$2.89
Share price
-6.76%
Change (1 day)
-13.85%
Change (1 year)

Fate Therapeutics (FATE) - Cash on Hand

Cash on Hand as of June 2024 : C$0.42 Billion

According to Fate Therapeutics 's latest financial reports the company has C$0.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Fate Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.41 B-29.38%
2022-12-31C$0.59 B-24.59%
2021-12-31C$0.78 B27.48%
2020-12-31C$0.61 B112.92%
2019-12-31C$0.28 B5.62%
2018-12-31C$0.27 B115.74%
2017-12-31C$0.12 B2.53%
2016-12-31C$0.12 B37.69%
2015-12-31C$89.9 M57.78%
2014-12-31C$56.98 M-0.94%
2013-12-31C$57.52 M536.57%
2012-12-31C$9.03 M39.08%
2011-12-31C$6.49 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.67 B 293.07%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.41 B 1,641.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.41 B 232.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.81 B 326.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.71 B 302.78%๐Ÿ‡บ๐Ÿ‡ธ USA